QTTB: Q32 Bio Inc. Stock

by  •  • Comments Off on QTTB: Q32 Bio Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 382.60
Enterprise Value ($M) 313.01
Book Value ($M) 18.30
Book Value / Share 1.50
Price / Book 20.91
NCAV ($M) 3.48
NCAV / Share 0.29
Price / NCAV 110.00

Profitability (mra)
Return on Invested Capital (ROIC) -1.36
Return on Assets (ROA) -1.13
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 8.82
Current Ratio 8.82

Balance Sheet (mrq) ($M)
Current Assets 89.72
Assets 104.54
Liabilities 86.25
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
6 days ago 13G/A 5AM Ventures IV, L.P. 0.00
7 days ago 13G Bristol Myers Squibb Co 6.23
10-25 13G/A Temasek Holdings (Private) Ltd 2.60
05-13 13G/A ARCH Venture Fund VIII, L.P.
04-04 13D Acorn Bioventures, L.p. 6.70
04-01 13D Atlas Venture Fund X, L.P. 7.20
03-29 13G Carlyle Group Inc. 9.20
03-28 13D Orbimed Advisors Llc 18.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-12 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A (Amendment No. 1) (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-19 16,838 84,439 19.94
2024-11-18 41,463 136,715 30.33
2024-11-15 25,419 110,519 23.00
2024-11-14 27,798 121,235 22.93

(click for more detail)

Similar Companies
PROC – Procaps Group S.A. PTGX – Protagonist Therapeutics, Inc.
PWUP – PowerUp Acquisition Corp. RANI – Rani Therapeutics Holdings, Inc.
RAPT – RAPT Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io